Accentia Biopharmaceuticals Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by ODONNELL FRANCIS E JR, was filed 29 Nov 2010.
Accentia Biopharmaceuticals Inc: what insiders have been doing
Accentia Biopharmaceuticals Inc is a listed company. Its directors and officers file their transactions with SEC (Form 4). No insider at Accentia Biopharmaceuticals Inc has published a filing in the past twelve months. The most recent one dates from 12 November 2013.
Since 2006, the database holds 10 purchases and 1 sale by insiders of the company.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
- 1,375,000 shares@ US$0.01Common StockSEC:0001214659-13-006340:0
- 500,000 shares0Common StockSEC:0001181431-12-055667:0
- 100,000 shares@ US$0.37Common StockSEC:0001181431-12-023953:0
- 375,000 shares0Common StockSEC:0001181431-12-009987:0
- 125,000 shares0Common StockSEC:0001181431-12-009987:1
- 500,000 shares@ US$0.20Common StockSEC:0001181431-11-061934:0
- 500,000 shares0Common StockSEC:0001181431-11-052080:0
- 66,000 sharesCommon StockSEC:0001181431-11-003303:0
- 206,896 shares0Common StockSEC:0001181431-10-063091:0
- 750,000 shares0Common StockSEC:0001181431-10-057910:0
- 750,000 shares0Common StockSEC:0001181431-10-057911:0
- 225,954 shares@ US$0.99Common StockSEC:0001181431-10-057911:1Canonical exit: 22 Feb 2011 (T+90)
- 13,600 shares@ US$0.9442Common StockSEC:0001181431-08-047976:0Canonical exit: 9 Nov 2008 (T+90)
- 11,400 shares@ US$0.95Common StockSEC:0001181431-08-047976:1Canonical exit: 10 Nov 2008 (T+90)
- 25,000 shares@ US$0.9365Common StockSEC:0001181431-08-047332:0Canonical exit: 6 Nov 2008 (T+90)
- 25,000 shares@ US$0.84Common StockSEC:0001181431-08-046649:0Canonical exit: 4 Nov 2008 (T+90)
- 25,000 shares@ US$0.79Common StockSEC:0001181431-08-046423:0Canonical exit: 3 Nov 2008 (T+90)
- 25,000 shares@ US$0.79Common StockSEC:0001181431-08-046103:0Canonical exit: 2 Nov 2008 (T+90)
- 25,000 shares@ US$0.86Common StockSEC:0001181431-08-045445:0Canonical exit: 29 Oct 2008 (T+90)
- 25,000 shares@ US$0.84Common StockSEC:0001181431-08-045445:1Canonical exit: 30 Oct 2008 (T+90)
- 875,000 shares@ US$8.87Common StockSEC:0001181431-07-052463:0Canonical exit: 12 Nov 2007 (T+90)
- 5,339 shares@ US$8.00Common StockSEC:0001181431-06-038226:1
- 252 shares@ US$8.00Common StockSEC:0001181431-06-038226:0
- 1,050 shares@ US$8.00Common StockSEC:0001181431-06-038223:0
- 4,333 shares@ US$8.00Common StockSEC:0001181431-06-038225:0
25 of 30 declarations
About Accentia Biopharmaceuticals Inc
Accentia Biopharmaceuticals Inc is a company focused on the development of biopharmaceutical products. It concentrates on innovative treatments for various diseases.
